As of June 20, 2025, Rock Creek Pharmaceuticals Inc (RCPIQ) reports a Current Ratio of 0.05.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Rock Creek Pharmaceuticals Inc's Current Ratio
Over recent years, Rock Creek Pharmaceuticals Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2015-12-31 | 0.05 |
| 2014-12-31 | 0.40 |
| 2013-12-31 | 2.27 |
| 2012-12-31 | 4.22 |
| 2011-12-31 | 2.66 |
This slight downward trend highlights how Rock Creek Pharmaceuticals Inc manages its short-term assets and liabilities over time.
Comparing Rock Creek Pharmaceuticals Inc's Current Ratio to Peers
To better understand Rock Creek Pharmaceuticals Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Rock Creek Pharmaceuticals Inc (RCPIQ) | 0.05 |
| Potent Ventures Inc (POT.CN) | 17.64 |
| Altrazeal Life Sciences Inc (ULUR) | 3.06 |
| Northstar Global Business Services Inc (MDIN) | 2.51 |
| Provention Bio Inc (PRVB) | 1.93 |
| Phoenix Life Sciences International Ltd (PLSI) | 1.76 |
Compared to its competitors, Rock Creek Pharmaceuticals Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.